Patient Teaching for Oral Chemotherapy and Biotherapy (PTCB)
With more and more oral chemotherapy and biotherapies being developed, cancer therapies are moving from intravenous infusions in outpatient clinics to oral medications taken in the patient's home. However, there are significant safety and adherence issues when a patient is taking oral anti-cancer drugs in their home. The MASCC Oral Agent Teaching Tool (MOATT©) was designed by the Multinational Association of Supportive Care in Cancer (MASCC) to help healthcare providers consistently assess and educate patients who are taking oral agents to treat their cancer.
This 5 learning hour online course developed in collaboration with Cancer Care Ontario will not only introduce health care professionals to the MOATT© but will also cover safe handling precautions when administering and caring for patients receiving oral anti-cancer drugs. The course will describe using the MOATT© with the following three oral anti-cancer drugs as examples: capecitabine (Xeloda®), erlotinib (Tarceva®), and imatinib (Gleevec®).
Fee (CAD): $ 226.00